Jeffrey T. L. Smith
Hoofd Techniek/Wetenschap/O&O bij ZYMEWORKS INC.
Vermogen: - $ op 30-04-2024
Profiel
Jeffrey T.
L.
Smith was the founder of Lundbeck Seattle BioPharmaceuticals, Inc. (founded in 2004) where he held the title of Senior Vice President-Translational Medicine from 2013 to 2017.
He is currently working as a Research Member at the American College of Rheumatology since 2013 and as the Chief Medical Officer & Executive Vice President at Zymeworks, Inc. since 2024.
In his former positions, he worked as a Medical Director at Simbec Research Ltd.
from 1997 to 1999, as a Senior Director-Medical Research at Celltech R&D, Inc. from 1999 to 2004, as a Senior Clinical Physician at Procter & Gamble Co. from 1994 to 1995, as the Head-Clinical Pharmacology at Hoechst Marion Roussel Ltd.
(United Kingdom) from 1995 to 1997, and as a Senior Research Physician at Glaxo Research Laboratories from 1989 to 1994.
Dr. Smith obtained his undergraduate degree from the University of London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ZYMEWORKS INC.
-.--% | 05-01-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Jeffrey T. L. Smith
| Bedrijven | Functie | Begin |
|---|---|---|
| ZYMEWORKS INC. | Hoofd Techniek/Wetenschap/O&O | 04-01-2024 |
American College of Rheumatology
 American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services The American College of Rheumatology is an organization for physicians and health professionals. The non-profit company is based in Atlanta, GA. The company was founded by Göran Albert Torstensson Ando. | Corporate Officer/Principal | - |
Eerdere bekende functies van Jeffrey T. L. Smith
| Bedrijven | Functie | Einde |
|---|---|---|
Celltech R&D, Inc.
 Celltech R&D, Inc. Drugstore ChainsRetail Trade Celltech R&D, Inc. provides research and development services for pharmaceutical products. The private company is based in Bothell, WA. | Corporate Officer/Principal | 01-01-2004 |
Simbec Research Ltd.
 Simbec Research Ltd. Miscellaneous Commercial ServicesCommercial Services Simbec Research Ltd. provides clinical research service to pharmaceutical and biotechnology industries. It conducts drug trails for allergy, anti-infectives, cardiovascular, gastrointestinal, anti-inflammatory, oncology and respiratory. The firm also offers consultancy services, preparation of marketing authorization applications, and clinical trial applications. The company was founded in 1976 and is headquartered in Merthyr Tydfil, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | 01-01-1999 |
Hoechst Marion Roussel Ltd. (United Kingdom)
 Hoechst Marion Roussel Ltd. (United Kingdom) Pharmaceuticals: OtherHealth Technology Founded in 1994, Hoechst Marion Roussel Ltd. (United Kingdom) is a British pharmaceutical company that manufactures pharmaceutical products. Part of Sanofi, the company is based in Guildford, UK. | Corporate Officer/Principal | 01-01-1997 |
| PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | 01-01-1995 |
| Glaxo Research Laboratories | Corporate Officer/Principal | 01-01-1994 |
Opleiding van Jeffrey T. L. Smith
| University of London | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| ZYMEWORKS INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Celltech R&D, Inc.
Celltech R&D, Inc. Drugstore ChainsRetail Trade Celltech R&D, Inc. provides research and development services for pharmaceutical products. The private company is based in Bothell, WA. | Retail Trade |
American College of Rheumatology
American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services The American College of Rheumatology is an organization for physicians and health professionals. The non-profit company is based in Atlanta, GA. The company was founded by Göran Albert Torstensson Ando. | Commercial Services |
Hoechst Marion Roussel Ltd. (United Kingdom)
Hoechst Marion Roussel Ltd. (United Kingdom) Pharmaceuticals: OtherHealth Technology Founded in 1994, Hoechst Marion Roussel Ltd. (United Kingdom) is a British pharmaceutical company that manufactures pharmaceutical products. Part of Sanofi, the company is based in Guildford, UK. | Health Technology |
| Glaxo Research Laboratories | |
Simbec Research Ltd.
Simbec Research Ltd. Miscellaneous Commercial ServicesCommercial Services Simbec Research Ltd. provides clinical research service to pharmaceutical and biotechnology industries. It conducts drug trails for allergy, anti-infectives, cardiovascular, gastrointestinal, anti-inflammatory, oncology and respiratory. The firm also offers consultancy services, preparation of marketing authorization applications, and clinical trial applications. The company was founded in 1976 and is headquartered in Merthyr Tydfil, the United Kingdom. | Commercial Services |
